An early and late peak in microglial activation in Alzheimer's disease trajectory

Autor: A Okello, Zhen Fan, David J. Brooks, Paul Edison
Přispěvatelé: Medical Research Council (MRC)
Rok vydání: 2016
Předmět:
0301 basic medicine
BIOMARKER
Male
Pathology
CLEARANCE
FLUID SOLUBLE TREM2
Cohort Studies
0302 clinical medicine
PARKINSONS-DISEASE
Carbon Radioisotopes
BRAIN
microglial activation
11 Medical and Health Sciences
Brain Mapping
Aniline Compounds
Microglia
biology
DEMENTIA
Neurodegeneration
NEURODEGENERATION
Alzheimer's disease
Middle Aged
AMYLOID-BETA
Magnetic Resonance Imaging
17 Psychology and Cognitive Sciences
medicine.anatomical_structure
Biomarker (medicine)
Female
amyloid imaging
Life Sciences & Biomedicine
Alzheimer’s disease
medicine.medical_specialty
Amyloid
Amyloid beta
Clinical Neurology
Antineoplastic Agents
Neuropathology
NEUROINFLAMMATION
03 medical and health sciences
POSITRON-EMISSION-TOMOGRAPHY
mild cognitive impairment
Imaging
Three-Dimensional

INFLAMMATION
Alzheimer Disease
mental disorders
medicine
Humans
Neuroinflammation
Aged
neuropathology
DECLINE
Science & Technology
Neurology & Neurosurgery
business.industry
Neurosciences
NEURONAL FUNCTION
Original Articles
medicine.disease
Isoquinolines
Thiazoles
030104 developmental biology
Positron-Emission Tomography
biology.protein
Neurology (clinical)
Neurosciences & Neurology
business
Cognition Disorders
Neuroscience
030217 neurology & neurosurgery
Zdroj: Fan, Z, Brooks, D J, Okello, A & Edison, P 2017, ' An early and late peak in microglial activation in Alzheimer's disease trajectory ', Brain, vol. 140, pp. 792-803 . https://doi.org/10.1093/brain/aww349
Popis: search input Search An early and late peak in microglial activation in Alzheimer’s disease trajectory Zhen Fan, David J. Brooks, Aren Okello, Paul Edison Brain, Volume 140, Issue 3, March 2017, Pages 792–803, https://doi.org/10.1093/brain/aww349 Published: 24 January 2017 Article history Received: 20 June 2016 Revision received: 31 October 2016 Accepted: 18 November 2016 Published: 24 January 2017 pdfPDF Split View Cite Permissions Icon Permissions Share Abstract Amyloid-β deposition, neuroinflammation and tau tangle formation all play a significant role in Alzheimer’s disease. We hypothesized that there is microglial activation early on in Alzheimer’s disease trajectory, where in the initial phase, microglia may be trying to repair the damage, while later on in the disease these microglia could be ineffective and produce proinflammatory cytokines leading to progressive neuronal damage. In this longitudinal study, we have evaluated the temporal profile of microglial activation and its relationship between fibrillar amyloid load at baseline and follow-up in subjects with mild cognitive impairment, and this was compared with subjects with Alzheimer’s disease. Thirty subjects (eight mild cognitive impairment, eight Alzheimer’s disease and 14 controls) aged between 54 and 77 years underwent 11C-(R)PK11195, 11C-PIB positron emission tomography and magnetic resonance imaging scans. Patients were followed-up after 14 ± 4 months. Region of interest and Statistical Parametric Mapping analysis were used to determine longitudinal alterations. Single subject analysis was performed to evaluate the individualized pathological changes over time. Correlations between levels of microglial activation and amyloid deposition at a voxel level were assessed using Biological Parametric Mapping. We demonstrated that both baseline and follow-up microglial activation in the mild cognitive impairment cohort compared to controls were increased by 41% and 21%, respectively. There was a longitudinal reduction of 18% in microglial activation in mild cognitive impairment cohort over 14 months, which was associated with a mild elevation in fibrillar amyloid load. Cortical clusters of microglial activation and amyloid deposition spatially overlapped in the subjects with mild cognitive impairment. Baseline microglial activation was increased by 36% in Alzheimer’s disease subjects compared with controls. Longitudinally, Alzheimer’s disease subjects showed an increase in microglial activation. In conclusion, this is one of the first longitudinal positron emission tomography studies evaluating longitudinal changes in microglial activation in mild cognitive impairment and Alzheimer’s disease subjects. We found there is an initial longitudinal reduction in microglial activation in subjects with mild cognitive impairment, while subjects with Alzheimer’s disease showed an increase in microglial activation. This could reflect that activated microglia in mild cognitive impairment initially may adopt a protective activation phenotype, which later change to a cidal pro-inflammatory phenotype as disease progresses and amyloid clearance fails. Thus, we speculate that there might be two peaks of microglial activation in the Alzheimer’s disease trajectory; an early protective peak and a later pro-inflammatory peak. If so, anti-microglial agents targeting the pro-inflammatory phenotype would be most beneficial in the later stages of the disease.
Databáze: OpenAIRE